HF
PMVP icon

HRT Financial’s PMV Pharmaceuticals PMVP Stock Holding History

HRT Financial’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-22,437
Closed -$23K – 3482
2025
Q2 		$23K Buy
+22,437
New +$22K ﹤0.01% 2382
2024
Q3 		– Sell
-12,014
Closed -$19K – 2975
2024
Q2 		$19K Buy
+12,014
New +$21.7K ﹤0.01% 1940
2023
Q3 		– Sell
-48,323
Closed -$302K – 2939
2023
Q2 		$302K Sell
48,323
-244,329
-83% -$1.28M ﹤0.01% 1628
2023
Q1 		$1.4M Buy
292,652
+137,450
+89% +$967K 0.02% 786
2022
Q4 		$1.35M Buy
155,202
+89,206
+135% +$951K 0.02% 770
2022
Q3 		$785K Buy
+65,996
New +$953K 0.01% 1088

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HRT Financial's PMVP Position: Q3 2025 in Review

HRT Financial sold out of PMV Pharmaceuticals (PMVP) in Q3 2025, closing a stake of 22,437 shares — an estimated $23K sold.

HRT Financial first reported a position in PMVP in Q3 2022 and held it in 6 quarters. The position peaked at $1.4M in Q1 2023. 64 funds tracked by Wall St. Rank hold PMVP as of Q3 2025.

  • HRT Financial reported no remaining PMV Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 22,437 PMV Pharmaceuticals shares in Q3 2025, an estimated $23K.
  • HRT Financial first reported a position in PMV Pharmaceuticals in Q3 2022 and held it in 6 quarters.
  • HRT Financial's PMV Pharmaceuticals position peaked at $1.4M in Q1 2023.
  • 64 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.